Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH) announced it has entered into a definitive merger agreement to acquire Kezar Life Sciences, Inc ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Mergers and Acquisitions